Getz’s appointment to the positions of EVP and CFO of the Guilford, Connecticut–based developer of handheld ultrasound technology will be made effective May 2.
“Heather brings a compelling blend of healthcare technology and public company experience along with a successful track record in operational and financial discipline that is well suited to support and enhance Butterfly’s continued growth and evolution,” Butterfly President and CEO Dr. Todd Fruchterman said in a news release. “As a proven CFO with deep experience in delivering results and value creation, Heather will be a strong partner as we continue to execute our strategy and introduce unique value to the healthcare ecosystem.”
Getz most recently spent 12 years at BioTelemetry where, among other positions, she held the roles of EVP and chief financial and administrative officer. Her time at BioTelemetry culminated in the $2.8 billion sale of the company to Royal Philips.
Prior to BioTelemetry, Getz’s financial leadership positions spanned companies including Alita Pharmaceuticals, Viasys Healthcare and Sunoco.
“I’m thrilled to join the Butterfly team at a time of significant opportunity for the company and its stakeholders,” Getz said. “Having played a leadership role in similar business situations and industries, I look forward to supporting Butterfly’s strategic plan to utilize its differentiated technology to fundamentally improve access to ultrasound acquired insights at the point-of-care, benefiting patients around the world.”
